📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial. (2022)

First Author: Coulson AB

Attributed to: TRAnsFORM: Trial Assessments of Fitness and Outcomes Research in Myeloma funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2021-056147

PubMed Identifier: 35654466

Publication URI: http://europepmc.org/abstract/MED/35654466

Type: Journal Article/Review

Volume: 12

Parent Publication: BMJ open

Issue: 6

ISSN: 2044-6055